Cancer BiologybioRxivPreprint
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease
Peter S. Winter, Michelle L. Ramseier, Andrew W. Navia…·Mark Alan Murakami
This study identifies mutation and transcriptional state compatibility in Ph+ ALL MRD, showing that targeting these interactions can overcome BCR::ABL1 independence and improve MRD monitoring.
3 citations